Addex Therapeutics (ADXN) Revenue (2022 - 2025)
Historic Revenue for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to $37157.2.
- Addex Therapeutics' Revenue fell 4020.31% to $37157.2 in Q3 2025 from the same period last year, while for Sep 2025 it was $132169.6, marking a year-over-year decrease of 7901.38%. This contributed to the annual value of $459343.4 for FY2024, which is 7442.31% down from last year.
- Addex Therapeutics' Revenue amounted to $37157.2 in Q3 2025, which was down 4020.31% from -$7039.6 recorded in Q2 2025.
- In the past 5 years, Addex Therapeutics' Revenue ranged from a high of $701646.0 in Q2 2023 and a low of -$7039.6 during Q2 2025
- Over the past 4 years, Addex Therapeutics' median Revenue value was $190375.2 (recorded in 2022), while the average stood at $257489.6.
- Per our database at Business Quant, Addex Therapeutics' Revenue soared by 26855.96% in 2023 and then tumbled by 10553.57% in 2025.
- Addex Therapeutics' Revenue (Quarter) stood at $614955.2 in 2022, then tumbled by 71.87% to $172993.7 in 2023, then plummeted by 99.0% to $1721.4 in 2024, then skyrocketed by 2058.53% to $37157.2 in 2025.
- Its Revenue was $37157.2 in Q3 2025, compared to -$7039.6 in Q2 2025 and $100330.6 in Q1 2025.